FDA Fine Tunes Guidance Disclaimers, May Undertake Broad Review
Executive Summary
FDA is considering undertaking a broad guidance clean-up effort, agency Chief Counsel Daniel Troy indicated May 16 during a Generic Pharmaceutical Association legal symposium in Washington, D.C
You may also be interested in...
USP Monographs Will Follow International Format For Drug Impurities
A new format for active pharmaceutical ingredient monographs will provide a more consistent approach to identify impurities, U.S. Pharmacopeia VP-Information & Standards Development Eric Sheinin, PhD, said
USP Monographs Will Follow International Format For Drug Impurities
A new format for active pharmaceutical ingredient monographs will provide a more consistent approach to identify impurities, U.S. Pharmacopeia VP-Information & Standards Development Eric Sheinin, PhD, said
FDA Guidance Practices Are Good Model For HHS – General Counsel Azar
FDA is a good role model for HHS agencies to follow in creating good guidance practices, HHS General Counsel Alex Azar told the Food & Drug Law Institute "lawyer's lunch" April 17